期刊文献+

参麦注射液联合化疗治疗晚期贲门癌的临床观察 被引量:5

Clinical Observation of Advanced Gastric Cardia Cancer Treated with Shenmai Injection Combined with Chemotherapy
下载PDF
导出
摘要 目的比较参麦注射液联合化疗与单纯化疗治疗晚期贲门癌的效果。方法将91例晚期贲门癌随机分为两组:治疗组46例,用参麦注射液静滴,配合FOLFOX-6方案化疗,对照组45例,单纯用FOLFOX-6方案化疗,评价疗效、毒副反应等情况。结果二组近期疗效无明显差异,但治疗组毒副反应有所减轻,其生活质量提高及中医症候改善明显,差异有显著性(P<0.01)。结论参麦注射液可减轻晚期贲门癌患者化疗所致毒副作用,改善生活质量。 Objective To compare the effect of Shenmai injection combined with chemotherapy for advanced gastric cancer treatment effect. Methods 91 cases of advanced cardia cancer were randomLy divided into two groups: the treatment group with Shenmai injection for intravenous drip, combined with FOLFOX-6 chemotherapy, the control group only with chemotherapy of FOLFOX-6 regimen, efficacy, toxicity. Results The treatment group reduced its toxicity, improve the quality of life and the Chinese medicine symptom improvement is obvious. Conclusion Shenmai injection can relieve advanced cardia cancer chemotherapy induced toxicity.
出处 《中国医药指南》 2013年第12期12-13,共2页 Guide of China Medicine
关键词 参麦注射液 晚期贲门癌 化疗 Shenmai injection Advanced gastric cardia Chemotherapy
  • 相关文献

参考文献5

二级参考文献49

共引文献134

同被引文献52

  • 1卢凯华,穆庆霞,王榕生,黄普文,仇金荣,刘连科,束永前.PFC方案治疗晚期食管贲门癌的临床观察[J].临床肿瘤学杂志,2005,10(2):143-144. 被引量:1
  • 2曹洋,李鹏,谭开基,陈锐深.参麦注射液防治晚期非小细胞肺癌化疗不良反应的临床观察[J].中国中西医结合杂志,2006,26(6):550-552. 被引量:28
  • 3张汀荣,许晨,沈伟生,张瑶,吕叶.参附注射液联合肉桂防治奥沙利铂神经毒性疗效观察[J].中国药房,2006,17(20):1570-1571. 被引量:20
  • 4陈桂荣,何家贤,钟文熹,徐汉杰.记忆合金支架在晚期食管贲门癌治疗中的应用[J].中华临床医师杂志(电子版).2013(01)
  • 5Grisold W,Cavaletti G,Windebank AJ.Peripheral neuropathies from chemotherapeutics and targeted agents:diagnosis,treatment,and prevention[J].Neuro Oncol,2012,14(Suppl 4):45-54.
  • 6Smith EM,Pang H,Cirrincione C,et al.Effect of duloxetine on pain,function,and quality of life among patients with chemotherapy-induced painful peripheral neuropathy:a randomized clinical trial[J].JAMA,2013,309(13):1359-1367.
  • 7Beijers AJ,Jongen JL,Vreugdenhil G.Chemotherapy-induced neurotoxicity:the value of neuroprotective strategies[J].Neth J Med,2012,70(1):18-25.
  • 8Gamelin E,Gamelin L,Bossi L,et al.Clinical aspects and molecular basis of oxaliplatin neurotoxicity:current management and development of preventive measures[J].Semin Oncol,2002,29(5 Suppl 15):21-33.
  • 9Levi F,Perpoint B,Gaxufi C,et al.Oxaliplatin activity against metastatic colorectal cancer.A phaseⅡstudy of 5-day continuous venous infusion at circadian ryhthm modulated rate[J].Eur J Cancer,1993,29(9):1280-1284.
  • 10Carozzi VA,Canta A,Chiorazzi A.Chemotherapy-induced peripheral neuropathy:what do we know about mechanisms[J].Neurosci Lett,2015,2(596):90-107.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部